Reference
- Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–5711. Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–571
- Guelfi J., Pull C. B. C.H.E.S.S.: Une check-liste pour l'évaluation des symptomes somatiques. 1979, In press2. Guelfi J., Pull C. B. C.H.E.S.S.: Une check-liste pour l'évaluation des symptomes somatiques. 1979, In press
- Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56–623. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56–62
- Overall J. E. Dimensions of manifest depressions. J. Psychiatr. Res. 1963; 1: 239–2454. Overall J. E. Dimensions of manifest depressions. J. Psychiatr. Res. 1963; 1: 239–245
- Overall J. E., Gorham D. R. The brief psychiatric rating scale. Psychol. Rep. 1962; 10: 799–8125. Overall J. E., Gorham D. R. The brief psychiatric rating scale. Psychol. Rep. 1962; 10: 799–812
- Pichot P., Lemperière A. Analyse factorielled'un questionnaire d'auto-évaluation des symptomes dépressifs. Rev. Psychol. Appl. 1964; 14: 15–196. Pichot P., Lemperière A. Analyse factorielled'un questionnaire d'auto-évaluation des symptomes dépressifs. Rev. Psychol. Appl. 1964; 14: 15–19
- Pull C. B., Pichot P., Pull M. C., von Frenckell R. The principal dimensions of manifest depression: a factor analysis of manifest depressive symptomatology. Neuropsychobiology 1979; 5: 207–2127. Pull C. B., Pichot P., Pull M. C., von Frenckell R. The principal dimensions of manifest depression: a factor analysis of manifest depressive symptomatology. Neuropsychobiology 1979; 5: 207–212
- Rogers S. C., Clay P. M. A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illness. Br. J. Psychiatry 1975; 127: 599–6038. Rogers S. C., Clay P. M. A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illness. Br. J. Psychiatry 1975; 127: 599–603
- Åsberg M., Cronholm B., Sjöqvist F., Tuck D. Relationship between plasma level and therapeutic effect of nortriptyline. Br. Med. J. 1971; 3: 3319. Åsberg M., Cronholm B., Sjöqvist F., Tuck D. Relationship between plasma level and therapeutic effect of nortriptyline. Br. Med. J. 1971; 3: 331
- Braithwaite R. A., Nakro B. R. S., Gaind R. Steady state plasma concentrations during single and multiple dosage schedules of amitriptyline. Psychol. Med. 1974; 4: 33810. Braithwaite R. A., Nakro B. R. S., Gaind R. Steady state plasma concentrations during single and multiple dosage schedules of amitriptyline. Psychol. Med. 1974; 4: 338
- Kragh-Sorensen P., Åsberg M., Eggert-Hansen C. Plasma nortriptyline levels in endogenous depression. Lancet 1973; 1: 11311. Kragh-Sorensen P., Åsberg M., Eggert-Hansen C. Plasma nortriptyline levels in endogenous depression. Lancet 1973; 1: 113
- Montgomery S., Braithwaite R. A., Cramer J. L. Routine nortriptyline levels in treatment of depression. Br. Med. J. 1977; 2: 16612. Montgomery S., Braithwaite R. A., Cramer J. L. Routine nortriptyline levels in treatment of depression. Br. Med. J. 1977; 2: 166
- Montgomery S., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night-time and divided dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S, Suppl. 113. Montgomery S., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night-time and divided dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S, Suppl. 1
- Ziegler V. E., Clayton P. J., Taylor J. R., Co B. T., Biggs J. T. Nortriptyline levels and therapeutic response. Clin. Pharmacol. Ther. 1976; 20: 45814. Ziegler V. E., Clayton P. J., Taylor J. R., Co B. T., Biggs J. T. Nortriptyline levels and therapeutic response. Clin. Pharmacol. Ther. 1976; 20: 458